Bei‐Ge Jiang

833 citations

27 papers · 650 indexed · h-index 15

Impact in

Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in ⓘ

Surgery 11
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Pancreatic function and diabetes 3
Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 9

Co-authors: Liang Sun (4 shared papers)Weiping Zhou (11 shared papers)Zhimin Liu (1 shared paper)Junjie Zou (1 shared paper)Yongquan Shi (1 shared paper)Ze‐Ya Pan (12 shared papers)Limei Li (3 shared papers)Jian Huang (9 shared papers)
Journals: Oncotarget (4 papers)Cancer Medicine (2 papers)Clinical Cancer Research (1 paper)Medicine (1 paper)Nanomedicine (1 paper)
Partner nations: China Hong Kong United States

In The Last Decade

Bei‐Ge Jiang

26 papers receiving 646 citations

Peers

Countries citing papers authored by Bei‐Ge Jiang

Since Specialization

Citations

This map shows the geographic impact of Bei‐Ge Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei‐Ge Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei‐Ge Jiang more than expected).

Fields of papers citing papers by Bei‐Ge Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bei‐Ge Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei‐Ge Jiang. The network helps show where Bei‐Ge Jiang may publish in the future.

Co-authors

The 25 scholars most cited alongside Bei‐Ge Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bei‐Ge Jiang Line = papers co-authored together Bei‐Ge Jiang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression Diabetes Research and Clinical Practice ·Liang Sun, Bei‐Ge Jiang, Wentong Li, Junjie Zou, Yongquan Shi, Zhimin Liu	2010	137
2	Double‐negative feedback loop between MicroRNA‐422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis Hepatology ·Jin Zhang, Yun Yang, Tian Yang, Shengxian Yuan, Ruoyu Wang, Ze‐Ya Pan, Yuan Yang, Gang Huang, Fangming Gu, Bei‐Ge Jiang, Chuan Lin, Weiping Zhou	2014	65
3	The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma Clinical Cancer Research ·Liang Tang, Yexiong Tan, Bei‐Ge Jiang, Yufei Pan, Shuangxi Li, Guang-Zhen Yang, Min Wang, Qing Wang, Jian Zhang, Weiping Zhou, Liwei Dong, Hongyang Wang	2013	51
4	Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes Nanomedicine Nanotechnology Biology and Medicine ·Jian Wang, Zhitao Wu, Guoyu Pan, Jun-sheng Ni, Fangyuan Xie, Bei‐Ge Jiang, Lixin Wei, Jie Gao, Weiping Zhou	2017	40
5	HNF1A：From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus Frontiers in Endocrinology ·Limei Li, Bei‐Ge Jiang, Liang Sun	2022	37
6	P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma Acta Pharmacologica Sinica ·Zheping Fang, Bei‐Ge Jiang, Xuefeng Gu, Bin Zhao, Ruiliang Ge, Fabiao Zhang	2013	36
7	SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts Cancer Letters ·Changzheng Wang, Hongwei Lv, Wen Yang, Ting Li, Tian Fang, Guishuai Lv, Qin Han, Liwei Dong, Tianyi Jiang, Bei‐Ge Jiang, Guang-Shun Yang, Hongyang Wang	2017	36
8	Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients Oncotarget ·Bei‐Ge Jiang, Neng Wang, Jian Huang, Yuan Yang, Liangliang Sun, Ze‐Ya Pan, Weiping Zhou	2017	28
9	Therapeutic PEG-ceramide Nanomicelles Synergize With Salinomycin to Target Both Liver Cancer Cells and Cancer Stem Cells Nanomedicine ·Meiping Wang, Fangyuan Xie, Xikai Wen, Han Chen, Hai Zhang, Junjie Liu, He Zhang, Hao Zou, Yu Yuan, Yan Chen, Zhiguo Sun, Xinxia Wang, Guoqing Zhang, Chuan Yin, Duxin Sun, Jie Gao, Bei‐Ge Jiang, Yanqiang Zhong, Ying Lü	2017	27
10	Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection Cancer Medicine ·Jian Huang, Fuchen Liu, Li Li, Weiping Zhou, Bei‐Ge Jiang, Ze‐Ya Pan	2020	26
11	Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice International Journal of Molecular Medicine ·Liang Sun, Tianjin Liu, Limei Li, Wei Tang, Junjie Zou, Xiangfang Chen, Jiaoyang Zheng, Bei‐Ge Jiang, Yongquan Shi	2017	24
12	Retrospective Analysis of Histopathologic Prognostic Factors After Hepatectomy for Intrahepatic Cholangiocarcinoma The Cancer Journal ·Bei‐Ge Jiang, Liangliang Sun, Wenlong Yu, Zhaohui Tang, Ming Zong, Yongjie Zhang	2009	21
13	A High Preoperative Platelet-Lymphocyte Ratio Is a Negative Predictor of Survival After Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Study Frontiers in Oncology ·Yun Yang, Meng‐chao Wang, Tian Tao, Jian Huang, Shengxian Yuan, Lei Liu, Peng Zhu, Fangming Gu, Siyuan Fu, Bei‐Ge Jiang, Fuchen Liu, Ze‐Ya Pan, Weiping Zhou	2020	18
14	Clinical Parameters Predicting Survival Duration after Hepatectomy for Intrahepatic Cholangiocarcinoma SHILAP Revista de lepidopterología ·Bei‐Ge Jiang, Ruiliang Ge, Liangliang Sun, Ming Zong, Gongtian Wei, Yongjie Zhang	2011	16
15	Impact of preoperative TACE on incidences of microvascular invasion and long‐term post‐hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis Cancer Medicine ·Yun Yang, Kongying Lin, Lei Liu, You‐Wen Qian, Yuan Yang, Shengxian Yuan, Peng Zhu, Jian Huang, Fuchen Liu, Fangming Gu, Siyuan Fu, Bei‐Ge Jiang, Hui Liu, Ze‐Ya Pan, Wan Yee Lau, Weiping Zhou	2021	14
16	SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy Medicine ·Bei‐Ge Jiang, Yuan Yang, Hui Liu, Fangming Gu, Yun Yang, Lin-Hao Zhao, Sheng-xian Yuan, Ruoyu Wang, Jin Zhang, Weiping Zhou	2015	12
17	RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma Oncotarget ·Jian Zhang, Tianyi Jiang, Bei‐Ge Jiang, Chun Yang, Yexiong Tan, Ning Yang, Yufei Pan, Zhiwen Ding, Guang-Zhen Yang, Mengchao Wu, Liwei Dong, Hongyang Wang	2014	10
18	Rpb3 promotes hepatocellular carcinoma through its N-terminus Oncotarget ·Zheping Fang, Bei‐Ge Jiang, Fabiao Zhang, Aidong Wang, Yiming Ji, Yongfu Xu, Ji‐Cheng Li, Weiping Zhou, Weijie Zhou, Hai-Xiong Han	2014	9
19	Prognostic Nomogram for Hepatitis B Virus–related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection American Journal of Clinical Oncology ·Jian Huang, Fuchen Liu, Li Li, Shengxian Yuan, Yuan Yang, Bei‐Ge Jiang, Hui Liu, Ze‐Ya Pan	2019	9
20	Preoperative three-dimensional versus two-dimensional evaluation in assessment of patients undergoing major liver resection for hepatocellular carcinoma: a propensity score matching study Annals of Translational Medicine ·Pengpeng Li, Mengchao Wang, Yuan Yang, Hui Liu, Ze‐Ya Pan, Bei‐Ge Jiang, Wan Yee Lau, Gang Huang, Weiping Zhou	2020	8

About Bei‐Ge Jiang

Bei‐Ge Jiang is a scholar working on Surgery, Hepatology, Molecular Biology, Cancer Research and Oncology, having authored 27 papers that have together received 650 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer, Lipids, and Metabolism (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Pancreatic function and diabetes (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), MicroRNA in disease regulation (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). The work is most often cited by research in Cancer Research (219 citations), Hepatology (111 citations), Oncology (135 citations), Molecular Biology (308 citations) and Surgery (168 citations). Bei‐Ge Jiang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Liang Sun, Weiping Zhou, Zhimin Liu, Junjie Zou, Yongquan Shi, Ze‐Ya Pan, Limei Li, Jian Huang, Yuan Yang and Fangming Gu. Their work appears in journals such as Oncotarget, Cancer Medicine, Clinical Cancer Research, Medicine and Nanomedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact